HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33,893,898 | +190.7% | 887,274 | +174.5% | 0.06% | +215.8% |
Q2 2023 | $11,660,900 | +25.8% | 323,285 | +33.2% | 0.02% | +26.7% |
Q1 2023 | $9,268,827 | -59.1% | 242,703 | -39.1% | 0.02% | -61.5% |
Q4 2022 | $22,658,490 | -22.9% | 398,216 | -46.5% | 0.04% | -25.0% |
Q3 2022 | $29,405,000 | +6.8% | 743,687 | +18.8% | 0.05% | +13.0% |
Q2 2022 | $27,545,000 | -1.2% | 626,042 | -10.4% | 0.05% | +31.4% |
Q1 2022 | $27,872,000 | -22.1% | 698,904 | -21.5% | 0.04% | -12.5% |
Q4 2021 | $35,784,000 | – | 889,937 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |